Schroeder, T
Fenk, R
Haas, R
Germing, U
Kobbe, G
Article History
First Online: 3 August 2015
Competing interests
: TS had a consulting role for Celgene Corporation, Germany and received financial travel support and lecture fees from Celgene Corporation, Germany. RF had a consulting role for Celgene Corporation, Germany and received honoraria, research funding and financial travel support from Celgene Corporation, Germany. UG received a speakers honorarium and research support from Celgene, Novartis and Janssen-Cilag. GK received financial travel support, research funding and lecture fees from Celgene Corporation. The remaining author declares no conflict of interest.